성감염증 진단 시장 : 질병 유형별, 진단 테스트 유형별, 기기별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Sexually Transmitted Disease Diagnostics Market size was valued at USD 92,345.34 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.

Diagnostics for sexually transmitted diseases (STDs) are the several techniques and examinations used to find out if a person has a sexually transmitted infection (STI). These tests are essential for the early diagnosis, management, and control of sexually transmitted infections.

Sexually Transmitted Disease Diagnostics Market- Market Dynamics

Rising prevalence of STDs and advancement in diagnostics technologies like Point of Care (POCs) are expected to propel market demand

The market for STD diagnostics is significantly driven by the increased prevalence of STDs across the globe. The transmission of sexually transmitted diseases is facilitated by several factors, including altered sexual behavior, poor access to healthcare, and low awareness. The need for diagnostic testing is driven by public health efforts and awareness campaigns that encourage routine screening for sexually transmitted diseases. People are also more likely to seek testing services when efforts are made to lessen the stigma attached to testing and treatment. Through supporting research, putting screening programs into place, and providing financial assistance for diagnostic testing, government entities and non-profit groups frequently support STD prevention and control measures. This support makes testing services more accessible, which propels market expansion.

The accuracy, speed, and accessibility of STD diagnostics have been enhanced by developments in diagnostic technologies, such as rapid diagnostic tests (RDTs), point-of-care testing (POCTs), and nucleic acid amplification tests (NAATs). Automation and advances in molecular diagnostics increase the effectiveness of testing procedures even more. Point-of-care testing solutions are in high demand due to the shift towards decentralized testing, especially in settings with limited resources or remote locations. Rapid diagnosis and prompt treatment are made possible by portable, user-friendly diagnostic equipment, which is essential for halting the spread of STDs.

Sexually Transmitted Disease Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2024-2032)

Based on Disease Type segmentation, the HIV/AIDS segment was predicted to show maximum market share in the year 2023, owing to the prevalence of HIV infections.

Based on Diagnostic Test Type segmentation, the laboratory testing segment was the leading Diagnostic Test Type in 2023, due to the high adoption of new tech at laboratory testing.

Based on Device segmentation, the laboratory devices segment was the leading Device in 2023, owing to the high demand for laboratory testing devices.

Based on region, North America was the leading revenue generator in 2023, owing to the presence of advanced healthcare solutions.

Sexually Transmitted Disease Diagnostics Market- Segmentation Analysis:

The Global Sexually Transmitted Disease Diagnostics Market is segmented based on Disease Type, Diagnostic Test Type, Device, and Region.

The market is divided into six categories based on Disease Type: Chlamydia, Gonorrhea, Syphilis, Genital herpes, Hepatitis B, and HIV/AIDS. The HIV/AIDS segment dominates the market. The growing prevalence of syphilis, gonorrhea, is also boosting the market growth.

The market is divided into two categories based on the Diagnostic Test Type: laboratory test and point of care testing. The laboratory testing segment dominates the market. The point of care testing is estimated to grow at the fastest CAGR over the forecast period.

The market is divided into two categories based on Device: laboratory devices and POC devices. The laboratory devices segment dominates the market and is expected to maintain its high dominance during the forecast period. High demand for blood tests, and other body testing devices are augmenting the segment growth.

Sexually Transmitted Disease Diagnostics Market- Geographical Insights

Globally, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is a dominating market for Sexually Transmitted Disease Diagnostics. In Asia Pacific, the increasing healthcare spending, particularly in emerging economies like China, India, contributes to the expansion of the STD diagnostics market. Greater investment in healthcare infrastructure, including laboratories and testing facilities, improves access to diagnostic services.

Sexually Transmitted Disease Diagnostics Market- Competitive Landscape:

The sexually transmitted disease diagnostics market is moderately consolidated. Market players are involved in strategic activities like technology innovation, development, and partnerships to expand their product & service portfolio and reach across the globe. Collaboration between diagnostic companies, healthcare providers, and public health agencies facilitates the development and deployment of innovative diagnostic solutions. Partnerships can also help expand market reach and improve distribution channels.

Recent Developments:

In May 2022, Qiagen Inc. introduced NeuMoDxHSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2) with approval from the European Commission.

In May 2022, The Food and Drug Administration approved Abbott's Alinity m STI Assay for STIs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET KEY PLAYERS

• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• Roche Diagnostics
• Cepheid
• Hologic, Inc.
• bioMerieux
• Siemens Healthineers
• QIAGEN Inc.
• Danaher Corporation
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• GenMark Diagnostics
• OraSure Technologies
• Mylan N.V.
• Alere Inc.
• Others

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

• Chlamydia
• Gonorrhea
• Syphilis
• Genital herpes
• Hepatitis B
• HIV/AIDS

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TEST TYPE- MARKET ANALYSIS, 2019-2032

• Laboratory Testing
• Point Of Care Testing

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DEVICE- MARKET ANALYSIS, 2019-2032

• Laboratory Devices
• Point of Care Devices

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Sexually Transmitted Disease Diagnostics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Sexually Transmitted Disease Diagnostics Market Snippet by Disease Type
  • 2.1.2. Sexually Transmitted Disease Diagnostics Market Snippet by Diagnostic Test Type
  • 2.1.3. Sexually Transmitted Disease Diagnostics Market Snippet by Device
  • 2.1.4. Sexually Transmitted Disease Diagnostics Market Snippet by Country
  • 2.1.5. Sexually Transmitted Disease Diagnostics Market Snippet by Region
• 2.2. Competitive Insights

3. Sexually Transmitted Disease Diagnostics Key Market Trends

• 3.1. Sexually Transmitted Disease Diagnostics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Sexually Transmitted Disease Diagnostics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Sexually Transmitted Disease Diagnostics Market Opportunities
• 3.4. Sexually Transmitted Disease Diagnostics Market Future Trends

4. Sexually Transmitted Disease Diagnostics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Sexually Transmitted Disease Diagnostics Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Sexually Transmitted Disease Diagnostics Market Landscape

• 6.1. Sexually Transmitted Disease Diagnostics Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Sexually Transmitted Disease Diagnostics Market - By Disease Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
  • 7.1.2. Chlamydia
  • 7.1.3. Gonorrhea
  • 7.1.4. Syphilis
  • 7.1.5. Genital herpes
  • 7.1.6. Hepatitis B
  • 7.1.7. HIV/AIDS

8. Sexually Transmitted Disease Diagnostics Market - By Diagnostic Test Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Diagnostic Test Type, 2024 & 2032 (%)
  • 8.1.2. Laboratory Testing
  • 8.1.3. Point Of Care Testing

9. Sexually Transmitted Disease Diagnostics Market - By Device

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Device, 2024 & 2032 (%)
  • 9.1.2. Laboratory Devices
  • 9.1.3. Point of Care Devices

10. Sexually Transmitted Disease Diagnostics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Sexually Transmitted Disease Diagnostics Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Abbott Laboratories
  • 11.2.2. Becton, Dickinson and Company (BD)
  • 11.2.3. Roche Diagnostics
  • 11.2.4. Cepheid
  • 11.2.5. Hologic, Inc.
  • 11.2.6. bioMerieux
  • 11.2.7. Siemens Healthineers
  • 11.2.8. QIAGEN Inc.
  • 11.2.9. Danaher Corporation
  • 11.2.10. Thermo Fisher Scientific
  • 11.2.11. Bio-Rad Laboratories
  • 11.2.12. GenMark Diagnostics
  • 11.2.13. OraSure Technologies
  • 11.2.14. Mylan N.V.
  • 11.2.15. Alere Inc.
  • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us